NEW YORK (GenomeWeb News) – Hologic yesterday reported that its second-quarter revenues decreased around 7 percent to $402 million from $431 million year over year.

The Bedford, Mass.-based firm said that revenues from Third Wave Technologies, the molecular diagnostics maker it acquired last summer for $580 million, contributed $8.9 million in revenues for the quarter and $17.4 million for the first six months of its fiscal 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.